The oral glucagon-like peptide-1 (GLP-1) receptor agonist semaglutide (Rybelsus – Novo Nordisk), which was approved by the FDA in 2019 for treatment of type 2 diabetes in adults, has now also been approved to reduce the risk of major adverse cardiovascular events (MACE) in adults with type 2 diabetes who are at high risk for these events.1 The injectable GLP-1 receptor agonists semaglutide (Ozempic), dulaglutide (Trulicity), and liraglutide (Victoza) are also approved for cardiovascular risk reduction in patients with type 2 diabetes.
Acetaminophen has been considered the drug of choice for treatment of fever and pain during pregnancy for decades, but a recent announcement by the US Department of Health and Human Services (HHS) has prompted discussion about its effects on fetal neurodevelopment and the risk of autism.
Diet, exercise, and weight loss can improve glycemic control, but most patients with type 2 diabetes eventually require glucose-lowering pharmacotherapy. An A1C goal of <7% (while minimizing hypoglycemia) is recommended for most patients to prevent or reduce the microvascular complications of diabetes (retinopathy, nephropathy, neuropathy). An A1C target of <8% may be appropriate for patients who are older, have comorbid conditions, or are at risk of serious hypoglycemia-associated adverse events.
When counselling travelers about the need, benefits and risks of travel vaccines, the following factors must be considered: Environmental factors, e.g., destination, duration of exposure (including expected cumulative life-time exposure), epidemiological situation, travel style (low budget associated with higher risk), travel purpose (visiting friends or relatives [VFR] - often results in higher risk) Host factors include e.g. age, origin (potential exposure at home vs. at destination, is there an incremental risk?), pre-existing illness, particularly immune suppression (e.g. HIV, medication), pregnancy, nursing A structured discussion about required, routine and recommended vaccinations is beneficial Required by destination country: yellow fever (special rules based on the International Health Regulations), meningococcal disease (Hajj), COVID-19 Routine: usual childhood / adolescence / adult / senior citizen vaccinations. Programs differ between countries. Some proof of vaccination may be required for schools mainly in North America. Recommended: depending on exposure to risk (incidence rate, also incremental risk compared to home country), impact of infection, cost of vaccines, etc. Essentials when protecting travelers against vaccine preventable diseases: Set correct priorities; base decisions on epidemiological evidence; consider contraindications Always state that No vaccine is 100% effective; All vaccines may have adverse reactions, rarely serious ones.
This chapter discusses the raw materials contained and the percentage by weight of each raw material of various insect repellents. Some of the insect repellents discussed in the chapter include insect repellent cream, repellent gel, repellent towelette, repellent roll-on, and repellent stick. The chapter also discusses the suggested formulation procedure or manufacturing procedure and the source of the formula, that is, the company or organization that supplied the formula of those insect repellents. Repellent-saturated paper towelettes, for applying repellent preparations, have become increasingly popular. An all-day supply of inexpensive towelettes to treat the whole family can be conveniently carried in the pocket or purse. Individual paper towelettes, saturated with Intermediate 5734, are sealed in small, nonporous envelopes. Normally, several envelopes are sold in a conveniently-priced package. The consumer tears open an individual envelope and wipes his face, hands, and other exposed skin with the towelette to obtain protection against mosquitoes, flies, chiggers, etc.
Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
